Zeda, a medical technology startup, has raised an impressive $52 million in its Series B funding round. Led by founder Shrinivas Shetty, Zeda combines 3D printing and nanotechnologies to cater to the spine device market's needs. With the goal of applying these technologies to the orthopedic industry as a whole, Zeda offers an end-to-end solution for medical devices from concept to production. Rapid prototyping is made easy with Zeda's advanced design consultation and software ecosystem, allowing for the optimization of medical device designs and reducing time-to-market. 

Their open design and manufacturing ecosystem also reduce engineering iterations, getting your team to the finish line fast by prototyping and validating on the same equipment used in volume production. Zeda's strength lies in the benefits of 3D printing for medical devices, such as open lattice structures enabling up to 75% porosity encouraging nearby cell growth and osseointegration. Designs using more natural anatomical shapes can improve the distribution of force and avoid excess stress on any one part of the fusion site to facilitate recovery. With investments from Berkeley Catalyst Fund, Solvay, DOV Management, Boutique Venture Partners, Fives, Taiyo Nippon Sanso Innovation, and Michelin, Zeda is poised to revolutionize the medical equipment manufacturing industry.